• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过多孔膜从人胚胎干细胞中分离间充质干细胞的方法。

A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells.

作者信息

Hong Ki-Sung, Bae Daekyeong, Choi Youngsok, Kang Sun-Woong, Moon Sung-Hwan, Lee Hoon Taek, Chung Hyung-Min

机构信息

1 Department of Stem Cell Biology, School of Medicine, Konkuk University , Seoul, Republic of Korea.

出版信息

Tissue Eng Part C Methods. 2015 Mar;21(3):322-9. doi: 10.1089/ten.TEC.2014.0171. Epub 2014 Oct 7.

DOI:10.1089/ten.TEC.2014.0171
PMID:25190318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4346605/
Abstract

Pluripotent human embryonic stem cells (hESCs) acquire mesenchymal characteristics during the epithelial-mesenchymal transition (EMT) process. Here, we report a simple and an efficient isolation method for mesenchymal stem cells (MSCs) from hESCs undergoing EMT using a commercialized porous membrane transwell culture insert. Suspension culture of hESC colonies results in the formation of embryoid bodies, which adhered on the upper compartment of 8 μm porous membrane in the presence of EMG2-MV media. The population migrating through the permeable membrane to the lower compartment not only exhibited EMT markers but also expressed high levels of a panel of typical MSC surface antigen markers, and demonstrated multipotent differentiation capability. In addition, they have a prolonged proliferation capacity without characteristics and chromosomal changes. Furthermore, the isolated MSCs significantly enhanced cardiac functions in a rat model of myocardial infarction (MI) as measured by the left ventricle wall thickness (MI control, 32.9%±3.2% vs. hESCs-MSCs, 38.7%±2.4%), scar length (MI control, 46.1%±2.5% vs. hESCs-MSCs, 41.8%±1.3%), fibrosis area (MI control, 34.3%±1.6% vs. hESCs-MSCs, 28.9%±3.5%), and capillary density. Our findings demonstrate an ease with which hESCs-MSCs can be effectively isolated using the porous membrane, which overcomes the lack of availability of MSCs for therapeutic applications in various diseased animal models.

摘要

多能性人类胚胎干细胞(hESCs)在上皮-间质转化(EMT)过程中会获得间充质特征。在此,我们报告一种简单且高效的从经历EMT的hESCs中分离间充质干细胞(MSCs)的方法,该方法使用商业化的多孔膜Transwell培养插入物。hESC集落的悬浮培养导致胚状体形成,在存在EMG2-MV培养基的情况下,这些胚状体附着在8μm多孔膜的上室。穿过可渗透膜迁移到下室的细胞群体不仅表现出EMT标志物,还高表达一组典型的MSC表面抗原标志物,并具有多能分化能力。此外,它们具有延长的增殖能力且无特征性和染色体变化。此外,在心肌梗死(MI)大鼠模型中,通过左心室壁厚度(MI对照组,32.9%±3.2%对hESCs-MSCs,38.7%±2.4%)、瘢痕长度(MI对照组,46.1%±2.5%对hESCs-MSCs,41.8%±1.3%)、纤维化面积(MI对照组,34.3%±1.6%对hESCs-MSCs,28.9%±3.5%)和毛细血管密度测量,分离得到的MSCs显著增强了心脏功能。我们的研究结果表明,使用多孔膜可以轻松有效地分离hESCs-MSCs,这克服了在各种患病动物模型中用于治疗应用的MSCs缺乏可用性的问题。

相似文献

1
A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells.一种通过多孔膜从人胚胎干细胞中分离间充质干细胞的方法。
Tissue Eng Part C Methods. 2015 Mar;21(3):322-9. doi: 10.1089/ten.TEC.2014.0171. Epub 2014 Oct 7.
2
Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.源自人类胚胎干细胞和骨髓的间充质干细胞的免疫学特性比较。
Tissue Eng Part A. 2015 Feb;21(3-4):616-26. doi: 10.1089/ten.TEA.2013.0651. Epub 2015 Jan 8.
3
Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro.人胚胎干细胞来源的间充质干细胞的体内和体外免疫调节作用。
J Zhejiang Univ Sci B. 2011 Jan;12(1):18-27. doi: 10.1631/jzus.B1000074.
4
Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-RGD scaffold for bone repair.人胚胎干细胞来源的间充质干细胞接种于磷酸钙水泥-壳聚糖-RGD 支架修复骨缺损。
Tissue Eng Part A. 2013 Apr;19(7-8):915-27. doi: 10.1089/ten.TEA.2012.0172. Epub 2013 Jan 28.
5
Human embryonic stem cells and macroporous calcium phosphate construct for bone regeneration in cranial defects in rats.人胚胎干细胞与大孔磷酸钙支架用于大鼠颅骨缺损的骨再生
Acta Biomater. 2014 Oct;10(10):4484-93. doi: 10.1016/j.actbio.2014.06.027. Epub 2014 Jun 24.
6
Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.富集具有免疫抑制和抗炎特性的人 ESC 来源多能间充质干细胞,以防止实验性炎症性肠病。
Stem Cells. 2011 Feb;29(2):251-62. doi: 10.1002/stem.569.
7
Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow.人胚胎干细胞或骨髓间充质细胞诱导骨折修复。
J Orthop Res. 2011 Dec;29(12):1804-11. doi: 10.1002/jor.21480. Epub 2011 Jun 14.
8
[Growing of human embryonic stem cells on feeders derived from themselves].[在源自自身的饲养层上培养人类胚胎干细胞]
Yi Chuan. 2008 Dec;30(12):1567-73. doi: 10.3724/sp.j.1005.2008.01567.
9
Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells.人胚胎干细胞向双能间充质干细胞的分化
Stem Cells. 2006 Aug;24(8):1914-22. doi: 10.1634/stemcells.2005-0648. Epub 2006 Apr 27.
10
Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats.间充质干细胞既不完全获得成熟心肌细胞的电生理特性,也不会在梗死大鼠中引发室性心律失常。
Basic Res Cardiol. 2012 Jul;107(4):274. doi: 10.1007/s00395-012-0274-4. Epub 2012 Jun 29.

引用本文的文献

1
Angiogenic and Immunomodulatory effects of embryonic stem cell derived mesenchymal stem cells in a murine model of ischemic hindlimb.胚胎干细胞来源的间充质干细胞在小鼠缺血后肢模型中的血管生成和免疫调节作用
Sci Rep. 2025 Jul 1;15(1):20397. doi: 10.1038/s41598-025-08283-w.
2
A single-center, phase 1/2a trial of hESC-derived mesenchymal stem cells (MR-MC-01) for safety and efficacy in interstitial cystitis patients.一项关于人胚胎干细胞来源的间充质干细胞(MR-MC-01)治疗间质性膀胱炎患者安全性和有效性的单中心1/2a期试验。
Stem Cells Transl Med. 2025 May 19;14(5). doi: 10.1093/stcltm/szaf018.
3
Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions of mast cells and T cells.胚胎干细胞来源的间充质干细胞通过调节肥大细胞和 T 细胞的功能缓解实验性接触性荨麻疹。
Sci Rep. 2023 Dec 20;13(1):22694. doi: 10.1038/s41598-023-50258-2.
4
The Current Proceedings of PSC-Based Liver Fibrosis Therapy.基于PSC的肝纤维化治疗的当前进展
Stem Cell Rev Rep. 2023 Oct;19(7):2155-2165. doi: 10.1007/s12015-023-10592-4. Epub 2023 Jul 25.
5
MutSα and MutSβ as size-dependent cellular determinants for prime editing in human embryonic stem cells.MutSα和MutSβ作为人类胚胎干细胞中碱基编辑的大小依赖性细胞决定因素。
Mol Ther Nucleic Acids. 2023 May 18;32:914-922. doi: 10.1016/j.omtn.2023.05.015. eCollection 2023 Jun 13.
6
Activating transcription factor-2 supports the antioxidant capacity and ability of human mesenchymal stem cells to prevent asthmatic airway inflammation.激活转录因子-2 支持人骨髓间充质干细胞的抗氧化能力和预防哮喘气道炎症的能力。
Exp Mol Med. 2023 Feb;55(2):413-425. doi: 10.1038/s12276-023-00943-z. Epub 2023 Feb 10.
7
Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study.人胚胎干细胞来源的间充质干细胞治疗间质性膀胱炎的安全性:I 期研究。
Stem Cells Transl Med. 2022 Oct 21;11(10):1010-1020. doi: 10.1093/stcltm/szac065.
8
Immunomodulation of Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Rotator Cuff Tears Model.多能干细胞衍生的间充质干细胞在肩袖撕裂模型中的免疫调节作用
Biomedicines. 2022 Jun 29;10(7):1549. doi: 10.3390/biomedicines10071549.
9
High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells.尿嘧啶DNA糖基化酶的高表达决定了人类多能干细胞中C到T的替换。
Mol Ther Nucleic Acids. 2021 Nov 29;27:175-183. doi: 10.1016/j.omtn.2021.11.023. eCollection 2022 Mar 8.
10
Micro-endoscopy for Live Small Animal Fluorescent Imaging.小动物活体荧光显微内镜成像
Adv Exp Med Biol. 2021;1310:153-186. doi: 10.1007/978-981-33-6064-8_8.

本文引用的文献

1
Modification to the injection needle to a screw needle improves effective cell delivery in acute myocardial infarction.将注射针改为螺旋针可改善急性心肌梗死中细胞的有效递送。
Biotechnol Lett. 2014 Apr;36(4):859-68. doi: 10.1007/s10529-013-1414-0. Epub 2013 Dec 10.
2
Differentiation of hESCs into Mesodermal Subtypes: Vascular-, Hematopoietic- and Mesenchymal-lineage Cells.人胚胎干细胞向中胚层亚型的分化:血管、造血和间充质谱系细胞。
Int J Stem Cells. 2011 Jun;4(1):24-34. doi: 10.15283/ijsc.2011.4.1.24.
3
The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.使用源自人胚胎干细胞的纯化心肌细胞聚集物进行心肌梗死后的功能植入。
Biomaterials. 2013 May;34(16):4013-4026. doi: 10.1016/j.biomaterials.2013.02.022. Epub 2013 Mar 5.
4
Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.人胚胎干细胞来源的间充质基质细胞(hES-MSCs)在体内植入并支持造血而不抑制免疫功能:对现成的 ES-MSC 治疗的影响。
PLoS One. 2013;8(1):e55319. doi: 10.1371/journal.pone.0055319. Epub 2013 Jan 29.
5
A comparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic wounds.人脐带血和胚胎干细胞来源的内皮祖细胞在治疗慢性创面中的比较。
Biomaterials. 2013 Jan;34(4):995-1003. doi: 10.1016/j.biomaterials.2012.10.039. Epub 2012 Nov 3.
6
Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.从人类多能干细胞生成心肌细胞的新型二维定向分化系统的开发。
Int J Cardiol. 2013 Sep 20;168(1):41-52. doi: 10.1016/j.ijcard.2012.09.077. Epub 2012 Oct 6.
7
Multilineage differentiation potential of cells isolated from the human amniotic membrane.人羊膜细胞的多向分化潜能。
J Cell Biochem. 2010 Nov 1;111(4):846-57. doi: 10.1002/jcb.22769.
8
Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells.新型类胚体方法从人胚胎干细胞中分离间充质干细胞。
Tissue Eng Part A. 2010 Feb;16(2):705-15. doi: 10.1089/ten.tea.2008.0596.
9
Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine.人胚胎干细胞来源的间充质祖细胞——再生医学中的潜力
Stem Cell Res. 2009 Jul;3(1):39-50. doi: 10.1016/j.scr.2009.05.002. Epub 2009 May 19.
10
Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells.人胚胎干细胞来源的中胚层样上皮细胞转变为间充质祖细胞。
Tissue Eng Part A. 2009 Aug;15(8):1897-907. doi: 10.1089/ten.tea.2008.0351.